A detailed history of Center Star Asset Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Center Star Asset Management, LLC holds 20,000 shares of IBRX stock, worth $50,599. This represents 0.06% of its overall portfolio holdings.

Number of Shares
20,000
Previous 14,400 38.89%
Holding current value
$50,599
Previous $45,000 15.56%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$1.89 - $3.44 $10,584 - $19,264
5,600 Added 38.89%
20,000 $52,000
Q1 2025

Apr 09, 2025

BUY
$2.32 - $3.9 $33,408 - $56,160
14,400 New
14,400 $45,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.01B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.